Jan 26, 2023 by Kody KesterCould This New Drug Indication Be a Winner for Eli Lilly?The FDA could be just months away from approving Eli Lilly and Boehringer Ingelheim's drug candidate to treat a common condition.
Jan 26, 2023 by Kody KesterShould Income Investors Buy This Blue-Chip Dividend Stock?Managing other people's money has historically been a lucrative business.
Jan 26, 2023 by Kody KesterBuy These 2 Buffett-Owned Stocks in 2023 to Boost Your Passive IncomeBoth of these companies are among the most dominant consumer staples around.
Jan 25, 2023 by Kody KesterThis Underappreciated Growth Stock Could Have Huge Upside in 2023This health insurer appears poised to outperform the S&P 500 index for the third consecutive year in 2023.
Jan 25, 2023 by Kody Kester2 Great Income Stocks to Buy in 2023Income stocks are reliable performers through market downturns.
Jan 23, 2023 by Kody KesterWall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023It's difficult to imagine a future where healthcare isn't in high demand.
Jan 23, 2023 by Kody KesterWant Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023It doesn't get any safer for income investors than Dividend Kings.
Jan 22, 2023 by Kody Kester2 Warren Buffett Stocks to Buy Hand Over Fist in JanuaryBerkshire Hathaway's stakes in these two stocks are worth a combined $23 billion.
Jan 21, 2023 by Kody Kester2 Fast-Growing Dividend Stocks to Buy Hand Over Fist in 2023These two dividend stocks could have 7% to 17% upside this year.
Jan 21, 2023 by Kody KesterThis Dow Jones Stock Crushed the Market in 2022 -- Can It Do It Again?This pharmaceutical was the second-best performing Dow Jones stock in 2022 behind the energy giant Chevron.
Jan 20, 2023 by Kody KesterThis Impressive Growth Stock Could Have 23% Upside in 2023, According to Wall StreetThis health insurer has outperformed the market for three straight years.
Jan 19, 2023 by Kody KesterIs This Under-the-Radar Growth Stock a Buy?This company is a small player in the steadily growing medtech industry.
Jan 19, 2023 by Kody KesterIs This Hot Dividend Stock a Buy for Growth Investors?This health insurer is a world-class business. But does that make the stock a savvy buy?
Jan 18, 2023 by Kody KesterThis Blue Chip Income Stock Is a No-Brainer BuyConagra's product portfolio contains numerous household-name brands.
Jan 18, 2023 by Kody KesterThis Small-Cap Stock Is a No-Brainer BuyThis genomic test maker's stock was beaten down in 2022. But it could be heading for a rebound this year.
Jan 17, 2023 by Kody KesterCould This FDA Approval Boost AbbVie's Stock?Last month, one of its anti-psychotic drugs received approval from the Food and Drug Administration for another indication.
Jan 17, 2023 by Kody KesterBristol Myers Squibb Wins Another Approval for Its Multimillion-Dollar Cancer DrugA cutting-edge cancer treatment from the drugmaker was recently approved in Japan to treat a type of lymphoma.
Jan 17, 2023 by Kody Kester2 Companies That Could Be Worth $1 Trillion by 2038The number of trillion-dollar companies will likely expand. Here are two companies that could join the exclusive club in the next 15 years.
Jan 14, 2023 by Kody KesterLooking for a Winning Dividend Grower? Buy Nike StockNike has made investors considerably richer over the last two decades.
Jan 14, 2023 by Kody KesterBeat the Dow Jones With This Unstoppable Dividend StockUnitedHealth Group has significantly outperformed the Dow Jones index in the last 10 years.
